What is the recommended rate of infusion for meropenem (intravenous antibiotic) in patients with normal and impaired renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Meropenem Rate of Infusion: Guidelines for Clinical Practice

Meropenem should be administered by intravenous infusion over approximately 15-30 minutes for standard dosing, with extended infusion of 3-4 hours recommended for severe infections, especially when treating bacteria with high MICs. 1, 2

Standard Administration Guidelines

Normal Renal Function

  • Standard dosing: 500 mg every 8 hours for skin/soft tissue infections or 1 gram every 8 hours for intra-abdominal infections 1
  • Standard infusion rate: 15-30 minutes 1
  • Alternative administration: May be given as IV bolus injection over 3-5 minutes (for doses up to 1 gram) 1

Impaired Renal Function

Dosage adjustment based on creatinine clearance:

  • CrCl >50 mL/min: Standard dose every 8 hours
  • CrCl 26-50 mL/min: Standard dose every 12 hours
  • CrCl 10-25 mL/min: Half standard dose every 12 hours
  • CrCl <10 mL/min: Half standard dose every 24 hours 1, 2

Optimized Administration for Severe Infections

For critically ill patients or when treating bacteria with high MICs, extended infusion provides pharmacodynamic advantages:

  • Extended infusion: Administer over 3-4 hours to improve clinical and microbiological efficacy 3, 2
  • Continuous infusion: Consider for severe infections with risk of pharmacodynamic failure (deep infection sites, major pharmacokinetic changes, high MIC) 3, 2

Special Considerations

Continuous Renal Replacement Therapy

  • CVVH (Continuous Venovenous Hemofiltration): 1 gram every 8 hours is recommended for patients with severe infections undergoing CVVH 4
  • CVVHDF (Continuous Venovenous Hemodiafiltration): 500 mg every 12 hours may be sufficient 5

Elderly Patients

  • For patients over 59 years old with compromised renal function, consider reducing the dose to 10 mg/kg 2

Pharmacodynamic Principles

The efficacy of meropenem is time-dependent, requiring:

  • Plasma concentrations above MIC for at least 70% of the dosing interval 3
  • Higher target (Cmin/MIC of 4-6) for optimal efficacy in critically ill patients 3

Clinical Pearls and Pitfalls

  • Common pitfall: Standard short infusions may not achieve adequate time above MIC for less susceptible organisms
  • Solution: Extended infusion (3-4 hours) improves target attainment without increasing daily dose
  • Stability consideration: Solutions prepared with Sodium Chloride 0.9% may be stored for 1 hour at room temperature or 15 hours refrigerated; solutions with Dextrose 5% should be used immediately 1
  • Therapeutic drug monitoring: Consider for critically ill patients to optimize dosing and prevent treatment failure or antimicrobial resistance 6

By following these guidelines for meropenem infusion rates, clinicians can optimize antimicrobial efficacy while minimizing the risk of treatment failure and development of resistance.

References

Guideline

Antibiotic Therapy with Meropenem

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.